Volumes of adolescents and young adults seeking inpatient, outpatient care for eating disorders increased, particularly during the first year of the pandemic
U.S. Approaches Bird Flu Infection Record
The U.S. is quickly approaching a record number of wild birds and poultry affected by avian influenza, announced the U.S. Centers for Disease Control and Prevention (CDC) last week.
Since early 2022, more than 49 million birds have either died due to a Eurasian H5N1 avian virus infection or have been culled due to exposure to infected birds.
As of November 7, 2022, this news is nearing the largest bird flu outbreak in the U.S. that occurred in 2015.
Even so, the number of states affected in 2022 is already more than double the number of states involved in 2015.
International Visitors Must Continue Verifying COVID-19 Vaccination Status
The U.S. Transportation Security Administration (TSA) Acting Executive Assistant Administrator of Operations Support Austin Gould recently signed a new Security Directive that continues requiring certain non-residents entering the U.S. to present proof of COVID-19 vaccination.
TSA Security Directive 1544-21-03A applies to non-US citizens traveling on an airline effective November 9, 2022, and remains in effect until January 8, 2023.
International airlines must confirm that each Covered Individual has the following:
COVID-19 Tied to Higher Risk for New, Worsening Bladder Symptoms
Symptomatic infection tied to three times greater risk for developing new or worsening overactive bladder symptoms
Second, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
Absolute increase in 30-day relapse risk associated with the second or third vaccine dose is small
COVID-19 mRNA Vaccines Tied to Higher Risk for Myocarditis, Pericarditis
Authors say benefits of vaccination still outweigh risks, but some individuals should be aware of their higher risk
COVID-19 Travel Vaccination Requirement Extended into 2023
The U.S. Transportation Security Administration (TSA) quietly confirmed it will continue requiring proof of COVID-19 vaccination for certain non-residents to enter the U.S. in 2023
The TSA Security Directive 1544-21-03A becomes effective on November 9, 2022, and applies to non-US citizens until at least January 8, 2023, to limit the risk of COVID-19, including virus variants.
HIV and Monkeypox Combo Remain Global Concern
The WHO Emergency Committee recently acknowledged that some progress had been made in the global response to the multi-country outbreak of monkeypox since the last meeting.
The Committee held the consensus view on November 1, 2022, that the event continues to meet the criteria for a Public Health Emergency of International Concern and highlights the primary reasons for ongoing concern.
These include an emerging potential for more significant health impact in vulnerable populations, continuing risk of stigma and discrimination, and other outbreak gaps.
Europe Approves Single-dose RSV Option for Infants
The European Commission became the first regulatory body to approve preventing respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season with passive immunization.
AstraZeneca and Sanofi’s Beyfortus® (nirsevimab) approval in the European Union was announced on November 4, 2022.
However, the actual availability date in Europe was not disclosed today.